ArticlebioRxiv : the preprint server for biology2026
Deconvolution-derived cell-type expression targets for personal genome sequence-to-expression prediction.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Sequence-to-function models learn regulatory features from genomic sequence, but they remain limited in their ability to predict gene-expression differences among individuals. Cell-type-specific regulatory effects may be obscured in bulk RNA sequencing, whereas paired genotype and single-cell expression cohorts remain small. We evaluated whether deconvolution of bulk RNA-seq could provide scalable cell-type-specific targets for personal-genome expression prediction. GTEx v8 bulk RNA-seq from six tissues was deconvolved with BayesPrism using single-nucleus reference profiles, producing targets across 83 tissue-cell-type contexts. Deconvolved expression agreed with matched pseudobulked GTEx single-nucleus RNA-seq, with median donor-level Pearson correlations across genes ranging from 0.53 to 0.73 by tissue. We compared genotype-feature models, regressors trained on frozen Enformer representations, and fine-tuned Enformer and Borzoi models. Across random and nonlinear-enriched gene sets, sequence-derived approaches generally outperformed genotype-feature baselines, while frozen Enformer features were competitive with end-to-end fine-tuning. For the random gene set, Fisher-averaged Pearson correlations were 0.122-0.142 for sequence-derived approaches and 0.081-0.086 for genotype-feature baselines in a coverage-aware sensitivity analysis. Model performance was positively associated with deconvolution-pseudobulk agreement for sequence-derived models (
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.